Failure to Monitor Anticoagulant Use and Document Nonpharmacological Interventions for Psychoactive Medications
Summary
The facility failed to provide necessary pharmaceutical services for two residents. For one resident receiving Lovenox for anticoagulation, the medical record showed the medication order but did not show a physician's order for monitoring adverse reactions, and the record also lacked documented evidence of monitoring for adverse reactions such as bleeding. The resident's care plan included monitoring for bleeding and notifying the physician if symptoms developed, but the chart did not contain the required monitoring documentation. During interview and record review, the DSD and DON verified the absence of the physician's order and the lack of documentation for adverse reaction monitoring. For another resident receiving psychoactive medications, the record showed orders for duloxetine for depression manifested by refusal of care and tearfulness/crying, and valproic acid for mood stabilization manifested by angry outbursts. The resident's care plan referenced nonpharmacological approaches for depressed symptoms, but the record did not show that those approaches were actually ordered, provided, or documented. Review of the care plan for valproic acid also failed to show nonpharmacological interventions. The pharmacist's drug regimen reviews for January through March 2026 did not include recommendations specific to the duloxetine or valproic acid use. Facility policy required psychoactive medications to be used only when necessary and to include assessment of environmental causes, attempted alternative interventions, and documentation of behavioral management programs. The policy for high alert medications identified anticoagulants as requiring monitoring for unusual bleeding or other adverse reactions. Interviews with the DSD and DON confirmed there was no documented evidence of nonpharmacological interventions for the psychoactive medications and no physician's order or documentation for monitoring adverse reactions related to the anticoagulant.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.